ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,354.05
0.49%
Dow Jones
39,056.39
0.44%
Gold vs US Dollar
2,308.95
-0.26%
Brent Oil
83.58
0.86%
Bitcoin
61,533.89
-1.28%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV
  6. Diamedica Therapeutics (DMA)

  7. Diamedica Therapeutics (DMA) News

DiaMedica Inc. (DMA)

Diamedica Therapeutics
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:DMA
DateTimeSourceHeadlineSymbolCompany
30/07/201413:00Marketwired CanadaDiaMedica to Present at InvestMNt Conference on August 6, 2014TSXV:DMADiamedica Therapeutics
25/07/201421:30Marketwired CanadaDiaMedica Inc. Announces Results of Annual General and Special Meeting of ShareholdersTSXV:DMADiamedica Therapeutics
10/07/201413:30Marketwired CanadaDiaMedica Promotes Mark Robbins to Executive Vice PresidentTSXV:DMADiamedica Therapeutics
08/07/201422:09Marketwired CanadaDiaMedica Announces Stock Option GrantTSXV:DMADiamedica Therapeutics
07/07/201413:30Marketwired CanadaDiaMedica Appoints Rich Pilnik as Chairman of the Board of DirectorsTSXV:DMADiamedica Therapeutics
10/06/201412:30Marketwired CanadaDiaMedica to Present Clinical Abstract on DM199 at the 74th Annual American Diabetes Association ConferenceTSXV:DMADiamedica Therapeutics
10/06/201412:30MarketwiredDiaMedica to Present Clinical Abstract on DM199 at the 74th Annual American Diabetes Association ConferenceTSXV:DMADiamedica Therapeutics
05/06/201415:22Marketwired CanadaDiaMedica Announces Development UpdateTSXV:DMADiamedica Therapeutics
05/06/201415:22MarketwiredDiaMedica Announces Development UpdateTSXV:DMADiamedica Therapeutics
03/06/201415:56Marketwired CanadaDiaMedica Inc. Appoints Dr. Ralph A. DeFronzo to its Scientific Advisory BoardTSXV:DMADiamedica Therapeutics
03/06/201415:56MarketwiredDiaMedica Inc. Appoints Dr. Ralph A. DeFronzo to its Scientific Advisory BoardTSXV:DMADiamedica Therapeutics
27/05/201416:53Marketwired CanadaDiaMedica Announces Completion of Prospectus OfferingTSXV:DMADiamedica Therapeutics
20/05/201421:22Marketwired CanadaDiaMedica Inc. Announces Filing of Final ProspectusTSXV:DMADiamedica Therapeutics
12/05/201423:26Marketwired CanadaDiaMedica Inc. Finalizes Terms of Public OfferingTSXV:DMADiamedica Therapeutics
08/05/201412:05Marketwired CanadaDiaMedica Inc. Provides Update on Public OfferingTSXV:DMADiamedica Therapeutics
25/04/201422:50Marketwired CanadaDiaMedica Inc. Amends the Expiry Date of WarrantsTSXV:DMADiamedica Therapeutics
22/04/201421:05Marketwired CanadaDiaMedica Inc. Announces Public OfferingTSXV:DMADiamedica Therapeutics
17/04/201414:28Marketwired CanadaDiaMedica Inc. to Amend the Expiry Date of WarrantsTSXV:DMADiamedica Therapeutics
15/04/201414:00Marketwired CanadaDiaMedica to Present at the 2014 GTC Diabetes SummitTSXV:DMADiamedica Therapeutics
15/04/201414:00MarketwiredDiaMedica to Present at the 2014 GTC Diabetes SummitTSXV:DMADiamedica Therapeutics
07/04/201414:07MarketwiredDiaMedica Appoints John Savage as Chief Financial OfficerTSXV:DMADiamedica Therapeutics
07/04/201414:06Marketwired CanadaDiaMedica Appoints John Savage as Chief Financial OfficerTSXV:DMADiamedica Therapeutics
25/03/201416:14Marketwired CanadaGranite Creek Cancels Consulting AgreementTSXV:DMADiamedica Therapeutics
19/02/201413:30MarketwiredDiaMedica Files 20-F Registration Statement with U.S. SEC and Provides Clinical UpdateTSXV:DMADiamedica Therapeutics
19/02/201412:30Marketwired CanadaDiaMedica Files 20-F Registration Statement with U.S. SEC and Provides Clinical UpdateTSXV:DMADiamedica Therapeutics
05/02/201417:15MarketwiredDiaMedica to Present at 16th Annual BIO CEO & Investor ConferenceTSXV:DMADiamedica Therapeutics
05/02/201416:15Marketwired CanadaDiaMedica to Present at 16th Annual BIO CEO & Investor ConferenceTSXV:DMADiamedica Therapeutics
22/01/201422:10Marketwired CanadaDiaMedica Inc. Announces Partial Exercise of Over-Allotment OptionTSXV:DMADiamedica Therapeutics
09/01/201413:30MarketwiredDiaMedica Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of DM199 in Type 2 Diabetic PatientsTSXV:DMADiamedica Therapeutics
09/01/201412:30Marketwired CanadaDiaMedica Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of DM199 in Type 2 Diabetic PatientsTSXV:DMADiamedica Therapeutics
 Showing the most relevant articles for your search:TSXV:DMA

Your Recent History

LSE
BOO
Boohoo
LSE
POS
Plexus
LSE
CHLL
Chill Brands
LSE
AAZ
Anglo Asian Mining
LSE
RR.
Rolls-royce
LSE
VAST
Vast Resources
LSE
CSFS
Cornerstone Fs
LSE
AGL
Angle
LSE
PET
Petrel Resources
LSE
GCM
Gcm Resources
LSE
BARC
Barclays
LSE
KEFI
Kefi Gold And Copper
LSE
APH
Alliance Pharma
LSE
TERN
Tern
LSE
SYME
Supply@me Capital
LSE
SCLP
Scancell
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved